ValuEngine Upgrades Affimed Therapeutics to STRONG BUY

For today’s bulletin, we take a look at our latest STRONG BUY and BUY upgrades. We also provide a link to download a FREE STOCK REPORT on Affimed Therapeutics $AFMD, one of our top upgrades for the day. VALUATION WATCH: Overvalued stocks now make up 50.75% of our stocks assigned a valuation and 21.28% of … Read moreValuEngine Upgrades Affimed Therapeutics to STRONG BUY